NLGN1 and colorectal carcinoma: In conclusion, NLG1 as a cell-membrane integrated protein could be a therapeutic target on the surface of the CRC cells to inhibit the anti-inflammatory responses of the macrophages initiated by the exosomes of the CRC cells.